Data / Form D filings / EpiBiologics, Inc.
EpiBiologics, Inc.: Form D filings
EpiBiologics, Inc., a biotechnology company in San Mateo, CA, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on April 25, 2024, reports $73.1 million sold of a $73.1 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1900 ALAMEDA DE LAS PULGAS, SUITE 250, San Mateo, CA, 94403
- Phone
- (650) 452-3510
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1968158
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 25, 2024 | Amendment | $73,050,000 | $73,050,000 | 15 | Mar 21, 2022 | sec.gov | |
| Apr 28, 2023 | New notice | $50,050,000 | $30,030,000 | $20,020,000 | 13 | Mar 21, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jason Coloma | Director | |
| Ann Lee-Karlon | Executive Officer, Director | |
| Samuel Bjork | Director | |
| Alexandra Cantley | Director | |
| Mitchell Mutz | Executive Officer, Director | |
| Seiji Miyahara | Director | |
| James Wells | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Apr 22, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EpiBiologics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.